Profile data is unavailable for this security.
About the company
Toleranzia AB is a Sweden-based company engaged in the development of a platform technology for treatment of autoimmune diseases. The Company's main project is aimed against an autoimmune nerve-muscle disease and myasthenia gravis. The Company’s platform technology enables the development of therapies targeting the cause of the disease, which in the current situation is the usual treatment.
- Revenue in SEK (TTM)0.00
- Net income in SEK-8.33m
- Incorporated--
- Employees--
- LocationToleranzia ABErik Dahlbergsgatan 11AGOETEBORG 411 26SwedenSWE
- Websitehttps://www.toleranzia.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lipum AB (publ) | 0.00 | -38.09m | 76.39m | -- | -- | 2.72 | -- | -- | -5.99 | -5.99 | 0.00 | 3.66 | 0.00 | -- | -- | -- | -90.45 | -117.07 | -125.46 | -181.40 | -- | -- | -- | -228,691.20 | -- | -296.29 | 0.0559 | -- | -- | -- | 27.12 | -- | -- | -- |
| Wntresearch AB | 0.00 | -29.98m | 77.38m | 2.00 | -- | 2.14 | -- | -- | -0.218 | -0.218 | 0.00 | 0.1189 | 0.00 | -- | -- | -- | -83.84 | -88.93 | -96.02 | -107.90 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 14.08 | -- | -- | -- |
| Aqua Bio Technology ASA | 6.93m | -18.52m | 78.66m | 2.00 | -- | 42.75 | -- | 11.34 | -0.9101 | -0.9101 | 0.34 | 0.09 | 0.1381 | 0.67 | 2.59 | -- | -36.87 | -80.72 | -57.87 | -125.29 | 33.17 | 5.57 | -267.01 | -965.98 | 0.1799 | -6.87 | 0.9009 | -- | 349.88 | 42.04 | 1.97 | -- | -- | -- |
| Isofol Medical AB (publ) | 9.51m | -126.28m | 80.43m | 7.00 | -- | 0.5583 | -- | 8.46 | -0.7773 | -0.7773 | 0.0587 | 0.8921 | 0.0364 | -- | 1.13 | 731,692.30 | -48.32 | -62.40 | -60.76 | -78.48 | -1,005.95 | -- | -1,327.54 | -1,097.45 | -- | -- | 0.00001 | -- | -42.89 | -- | 20.22 | -- | -- | -- |
| Lidds AB | 1.33m | -36.74m | 81.88m | 3.00 | -- | 0.9373 | -- | 61.56 | -1.01 | -1.01 | 0.0365 | 1.28 | 0.027 | -- | 3.91 | -- | -74.61 | -27.78 | -88.27 | -29.92 | -- | -- | -2,762.03 | -1,045.58 | -- | -121.86 | 0.00 | -- | -46.88 | 12.92 | 1.10 | -- | -43.49 | -- |
| Ziccum AB | 0.00 | -27.38m | 82.56m | -- | -- | 3.36 | -- | -- | -1.97 | -1.97 | 0.00 | 1.78 | 0.00 | -- | -- | -- | -62.78 | -64.29 | -70.18 | -70.23 | -- | -- | -- | -35,465.64 | -- | -- | 0.0497 | -- | -- | -- | -36.20 | -- | -- | -- |
| Immunovia AB (publ) | 1.48m | -175.64m | 85.50m | 51.00 | -- | 0.2199 | -- | 57.66 | -7.37 | -7.37 | 0.0619 | 8.58 | 0.0042 | 42.36 | 13.12 | 23,171.88 | -50.00 | -28.84 | -54.29 | -30.54 | -5,440.80 | -9,524.69 | -11,843.43 | -22,080.23 | 2.59 | -- | 0.1561 | -- | 35.66 | 50.37 | -7.77 | -- | -44.66 | -- |
| Dextech Medical AB | 0.00 | -5.53m | 87.81m | 1.00 | -- | -- | -- | -- | -0.2992 | -0.2992 | 0.00 | -- | -- | -- | -- | -- | -- | -36.80 | -- | -38.28 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.26 | -- | -18.38 | -- |
| Odi Pharma AB (publ) | 126.32k | -6.75m | 88.28m | -- | -- | 17.60 | -- | 698.83 | -0.4433 | -0.4433 | 0.0083 | 0.3295 | 0.0138 | 0.1962 | 0.4192 | -- | -73.52 | -- | -81.73 | -- | -146.40 | -- | -5,340.67 | -- | 3.64 | -50.07 | 0.00 | -- | -- | -- | -81.81 | -- | -- | -- |
| Toleranzia AB | 0.00 | -8.33m | 89.36m | -- | -- | 0.7601 | -- | -- | -0.0755 | -0.0755 | 0.00 | 1.07 | 0.00 | -- | -- | -- | -6.54 | -9.51 | -6.80 | -9.95 | -- | -- | -- | -- | -- | -- | 0.0072 | -- | -- | -- | -35.32 | -- | 68.53 | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -7.95m | 90.33m | -- | -- | 0.2927 | -- | -- | -0.0533 | -0.0533 | 0.00 | 1.09 | 0.00 | -- | -- | -- | -4.96 | -5.03 | -5.05 | -5.18 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -59.41 | -- | -52.37 | -- |
| Peptonic Medical AB | 43.60m | -33.60m | 90.49m | -- | -- | 0.9569 | -- | 2.08 | -0.0764 | -0.0764 | 0.0809 | 0.0805 | 0.4539 | 1.38 | 5.24 | -- | -34.97 | -42.70 | -44.65 | -53.76 | 51.99 | 57.62 | -77.06 | -159.81 | 1.84 | -9.86 | 0.068 | -- | 37.89 | 256.60 | 49.98 | -- | -27.03 | -- |
| RLS Global AB | 982.00k | -26.72m | 95.85m | -- | -- | 3.91 | -- | 97.61 | -0.3491 | -0.3491 | 0.0133 | 0.3073 | 0.0402 | -- | 0.7323 | -- | -109.31 | -51.62 | -136.06 | -60.29 | -- | -- | -2,720.57 | -1,419.60 | 2.81 | -126.83 | 0.00 | -- | 83.46 | -12.51 | -116.81 | -- | -- | -- |
| Chosa Oncology AB | 4.21m | -33.75m | 95.92m | -- | -- | 3.22 | -- | 22.77 | -1.77 | -1.77 | 0.2185 | 0.4748 | 0.1006 | -- | 0.4479 | -- | -80.63 | -51.10 | -133.04 | -59.29 | -- | -- | -801.20 | -683.05 | -- | -- | 0.00 | -- | -58.66 | -- | 38.15 | -- | -- | -- |
| Orphazyme A/S | 0.00 | -59.99m | 100.85m | 1.00 | -- | 1.55 | -- | -- | -1.09 | 0.7392 | 0.00 | 1.18 | 0.00 | -- | -- | 0.00 | -33.12 | -66.58 | -89.20 | -85.98 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 51.19 | -- | -- | -- |
| 2cureX AB | 103.00k | -29.45m | 101.39m | -- | -- | 2.84 | -- | 984.40 | -1.67 | -1.67 | 0.0059 | 2.03 | 0.0019 | -- | 0.0243 | -- | -54.43 | -29.76 | -57.50 | -34.48 | -11,395.15 | -56,037.78 | -28,590.29 | -79,137.78 | -- | -- | 0.00 | -- | -- | 13.88 | -57.21 | -- | 138.57 | -- |
Data as of Jun 08 2023. Currency figures normalised to Toleranzia AB's reporting currency: Swedish Krona SEK
